{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:53:50Z","timestamp":1773298430700,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Macy's Foundation"},{"name":"Puglisi Gynecologic Oncology Research Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.gore.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T20:57:45Z","timestamp":1461790665000},"page":"26-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature"],"prefix":"10.1016","volume":"17","author":[{"given":"K.L.","family":"Hancock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.E.","family":"Dinkelspiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2016.04.003_bb0005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.gore.2016.04.003_bb0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.gore.2016.04.003_bb0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gore.2016.04.003_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma\u2014results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.gore.2016.04.003_bb0025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gore.2016.04.003_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","article-title":"Consensus statement on peritoneal mesothelioma","volume":"98","author":"Deraco","year":"2008","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2016.04.003_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.gore.2016.04.003_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.gore.2016.04.003_bb0045","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1177\/1066896910370880","article-title":"Malignant mesothelioma mimicking ovarian cancer","volume":"18","author":"Merino","year":"2010","journal-title":"Int. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.gore.2016.04.003_bb0050","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.gore.2016.04.003_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","article-title":"A review of peritoneal mesothelioma at the Washington Cancer Institute","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.gore.2016.04.003_bb0060","unstructured":"Surveillance, Epidemiology, and EndResults (SEER) Program. SEER*Stat Database: Incidence\u2014SEER 9 Regs Public-Use, Nov 2003 Sub (1973\u20132001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004."},{"key":"10.1016\/j.gore.2016.04.003_bb0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","article-title":"US mesothelioma patterns 1973\u20132002: indicators of change and insights into background rates","volume":"17","author":"Teta","year":"2008","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.gore.2016.04.003_bb0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000199880","article-title":"Malignant peritoneal mesothelioma: a series of 19 cases","volume":"43","author":"van Gelder","year":"1989","journal-title":"Digestion"},{"key":"10.1016\/j.gore.2016.04.003_bb0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","article-title":"Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma","volume":"117","author":"Varghese","year":"2011","journal-title":"Cancer"},{"issue":"8073","key":"10.1016\/j.gore.2016.04.003_bb0080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(78)90911-X","article-title":"Non-occupational exposure to asbestos and malignant mesothelioma in females","volume":"1","author":"Vianna","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.gore.2016.04.003_bb0085","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2016.04.003_bb0090","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578916300182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578916300182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:53:54Z","timestamp":1762480434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578916300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":18,"alternative-id":["S2352578916300182"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2016.04.003","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of mesothelioma masquerading pre-operatively as ovarian cancer and brief review of the literature","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}